Provention Bio, Inc. Profile Avatar - Palmy Investing

Provention Bio, Inc.

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and mon…

Biotechnology
US, Red Bank [HQ]

Resulting Ratios

6 Records · Starting from 2017
Loading...
End of PRVB's Analysis
CIK: 1695357 CUSIP: 74374N102 ISIN: US74374N1028 LEI: - UEI: -
Secondary Listings
PRVB has no secondary listings inside our databases.